
    
      Non-invasive prolactinomas were treated by transsphenoidal surgery or Dopamine agonist until
      now. Howeverï¼Œthis two type therapies were controversial. The study aim to investigate the
      endocrine remission rate of non-invasive prolactinoma between transsphenoidal surgery
      treatment and Dopamine agonist treatment.
    
  